Reversal of multidrug resistance by surfactants
1992

Reversal of Multidrug Resistance by Surfactants

Sample size: 6 publication Evidence: high

Author Information

Author(s): D.M. Woodcock, M.E. Linsenmeyer, G. Chojnowski, A.B. Kriegler, V. Nink, L.K. Webster, W.H. Sawyer

Primary Institution: Peter MacCallum Cancer Institute

Hypothesis

Can surfactants like Cremophor EL reverse multidrug resistance in cancer cells?

Conclusion

Cremophor EL and other surfactants can effectively reverse multidrug resistance in cancer cells, improving drug uptake and survival in treated mice.

Supporting Evidence

  • Cremophor EL was shown to reverse multidrug resistance in vitro.
  • Surfactants with polyethoxyl moieties were effective in reversing drug exclusion.
  • Combination treatment with adriamycin and Cremophor significantly increased survival in mice.
  • Cremophor did not cause significant cell lysis at effective concentrations.
  • Flow cytometry confirmed increased intracellular drug levels in treated cells.

Takeaway

Some special soaps can help cancer medicine work better by stopping cancer cells from pushing the medicine out.

Methodology

Flow cytometry was used to evaluate drug uptake and efflux in cancer cells treated with various surfactants.

Limitations

The study primarily focused on specific cell lines and may not fully represent all cancer types.

Participant Demographics

Mice with multidrug resistant tumors were used in the study.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication